JPRN-UMIN000009431已完成1 期
A phase I study of combined immunotherapy using alpha-galactosylceramide pulsed antigen presenting cells and autologous lymphocyte activated by autologous tumor tissue for patients with head and neck squamous cell carcinoma. - A phase I study of combined immunotherapy using alpha-GalCer pulsed APCs and activated autologous lymphocyte for patients with HNSCC.
Graduate School of Medicine, Chiba University, Department of Otorynolaryngology0 个研究点目标入组 9 人开始时间: 2012年11月29日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Past histry of hepatitis, a positive response for HBs antigen/HCT antibody/HIV antibody/HTL-V1 antibody, recieived concurrent corticosteroid therapy, pregnancy or lactation, antoimmune disease, infection, uncontrolled diabetes mellitus, pulmonary fibrosis, serious cardiac disease, double cancer, invasion into carotid artery, pleural effusion, brain metastasis, nutritional disorder, judgement of physician
研究者
相似试验
已完成
1 期
A phase I study of combination immunotherapy with five peptides cocktail, CpG, and immune modulators for patients with advanced or metastatic colorectal cancercolorectal cancerJPRN-UMIN000022082Yamaguchi University12
已完成
不适用
The phase I study of the combined immunotherapy using alpha-galactosylceramide pulsed antigen presenting cells and tumor-specific peptide pulsed dendritic cells for patients with advanced head and neck mucosal melanomaHead and neck mucosal malignant melanomaJPRN-UMIN000011508Department of Otorynolaryngology, Head and Neck Surgery9
已完成
不适用
A Phase I Trial of Combined immunotherapy with nivolumab and interferon-beta in Patients with advanced melanoma.advanced melanomaJPRN-UMIN000020222Tohoku University Graduate School of Medicine9
已完成
1 期
A phase I study of combination adjuvant immunotherapy for patients with resectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000029991Yamaguchi University Graduate School of Medicine20
进行中（未招募）
不适用
Pilot phase II study of a combined immunotherapy protocol based on oral vaccination and direct intratumoral injection of Salmonella Typhi Ty21a Vivotif in metastatic cutaneous melanoma patients. - NDMetastatic stage III e IV M1a melanomaMedDRA version: 6.1Level: PTClassification code 10042551EUCTR2005-005775-15-ITISTITUTO EUROPEO DI ONCOLOGIA43